FilingSEC EDGAR6-K
Cellyan Biotechnology Approves 1-for-20 Share Consolidation
· SEC accepted
StageApproved
Filing content
The extraordinary general meeting approved a 1-for-20 share consolidation and corresponding change in authorized share capital, effective upon Nasdaq confirmation.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…